Cited by 226Hormonal Regulation and HypertensionRenin-Angiotensin System StudiesDiabetes, Cardiovascular Risks, and Lipoproteins

The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.

Plasma Aldosterone Is Independently Associated With the Metabolic Syndrome

Bochud, Murielle, Nussberger, Jürg, Bovet, Pascal, Maillard, Marc R., Elston, Robert C., Paccaud, Fred, Shamlaye, Conrad, Burnier, Michel·2006·Hypertension

DOI 10.1161/01.hyp.0000231338.41548.fc

Open this paper in CoChat — free account

Abstract

The aim of this study was to analyze the associations of plasma aldosterone and plasma renin activity with the metabolic syndrome and each of its components. We analyzed data from a family based study in the Seychelles made up of 356 participants (160 men and 196 women) from 69 families of African descent. In multivariable models, plasma aldosterone was associated positively (P < 0.05) with blood pressure in older individuals (interaction with age, P < 0.05) and with waist circumference in men (interaction with sex, P < 0.05) and negatively with high-density lipoprotein cholesterol, in particular in individuals with elevated urinary potassium excretion (interaction with urinary potassium, P < 0.05); plasma renin activity was significantly associated with triglycerides and fasting blood glucose. Plasma aldosterone, but not plasma renin activity, was associated with the metabolic syndrome per se, independently of the association with its separate components. The observation that plasma renin activity was associated with some components of the metabolic syndrome, whereas plasma aldosterone was associated with other components of the metabolic syndrome, suggests different underlying mechanisms. These findings reinforce previous observations suggesting that aldosterone is associated with several cardiovascular risk factors and also suggest that aldosterone might contribute to the increased cardiovascular disease risk in individuals of African descent with the metabolic syndrome.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1161/01.hyp.0000231338.41548.fc

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.
(2002) · Circulation · doi:10.1161/circ.106.25.3143 · Cited by 14,092
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214
Definition of Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition
Grundy, S. M., Brewer, H. B., Cleeman, J. I., Smith, S. C., & Lenfant, C. (2004) · Circulation · doi:10.1161/01.cir.0000111245.75752.c6 · Cited by 5,982
Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction
Pitt, B., Remme, W., Zannad, F., Neaton, J., Martinez, F., Roniker, B., Bittman, R., Hurley, S., Kleiman, J., & Gatlin, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030207 · Cited by 4,941
Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome
Isomaa, B., Almgren, P., Tuomi, T., Forsén, B., Lahti, K., Nissén, M., Taskinen, M.-R., & Groop, L. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.683 · Cited by 4,760
The Metabolic Syndrome and 11-Year Risk of Incident Cardiovascular Disease in the Atherosclerosis Risk in Communities Study
McNeill, A. M., Rosamond, W. D., Girman, C. J., Golden, S. H., Schmidt, M. I., East, H. E., Ballantyne, C. M., & HEISS, G. M. (2005) · Diabetes Care · doi:10.2337/diacare.28.2.385 · Cited by 1,051
Clinical measurement of arterial stiffness obtained from noninvasive pressure waveforms
NICHOLS, W. (2005) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2004.10.009 · Cited by 1,008
Clinical Management of Metabolic Syndrome: Report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association Conference on Scientific Issues Related to Management
Grundy, S. M., Hansen, B., Smith, S. C., Cleeman, J. I., Kahn, R. A., & Participants, F. C. (2004) · Circulation · doi:10.1161/01.cir.0000112379.88385.67 · Cited by 864

Show all 55 references

Research works printed but not linked: 2

10.1161/hyp.25.1.30 · DOI
10.1161/hyp.37.3.845 · DOI

Sorted by citations

Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis
D’Agati, V. D., Chagnac, A., de Vries, A. P. J., Levi, M., Porrini, E., Herman‐Edelstein, M., & Praga, M. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.75 · Cited by 735
Adipocyte-Derived Hormone Leptin Is a Direct Regulator of Aldosterone Secretion, Which Promotes Endothelial Dysfunction and Cardiac Fibrosis
Huby, A.-C., Antonova, G., Groenendyk, J., Gomez-Sanchez, C. E., Bollag, W. B., Filosa, J. A., & de Chantemèle, E. J. B. (2015) · Circulation · doi:10.1161/circulationaha.115.018226 · Cited by 376
Narrative Review: The Emerging Clinical Implications of the Role of Aldosterone in the Metabolic Syndrome and Resistant Hypertension
Sowers, J. R., Whaley-Connell, A., & Epstein, M. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-11-200906020-00005 · Cited by 351
Aldosterone and end-organ damage
Brown, N. J. (2005) · Current Opinion in Nephrology & Hypertension · doi:10.1097/01.mnh.0000165889.60254.98 · Cited by 321
Enhanced Aldosterone Signaling in the Early Nephropathy of Rats with Metabolic Syndrome
Nagase, M., Yoshida, S., Shibata, S., Nagase, T., Gotoda, T., Ando, K., & Fujita, T. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006080944 · Cited by 247
Aldosterone and end-organ damage
Marney, A. M., & Brown, N. J. (2007) · Clinical Science · doi:10.1042/cs20070123 · Cited by 234
The Renin Angiotensin Aldosterone System and Insulin Resistance in Humans
UNDERWOOD, P. C., & Adler, G. K. (2012) · Current Hypertension Reports · doi:10.1007/s11906-012-0323-2 · Cited by 219
Body Mass Index Predicts Aldosterone Production in Normotensive Adults on a High-Salt Diet
Bentley–Lewis, R., Adler, G. K., Perlstein, T. S., Seely, E. W., Hopkins, P. N., Williams, G. H., & Garg, R. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1088 · Cited by 213
Association of Adrenal Steroids With Hypertension and the Metabolic Syndrome in Blacks
Kidambi, S., Kotchen, J. M., Grim, C. E., Raff, H., Mao, J., Singh, R., & Kotchen, T. A. (2006) · Hypertension · doi:10.1161/01.hyp.0000253258.36141.c7 · Cited by 212
Multimarker Approach to Evaluate the Incidence of the Metabolic Syndrome and Longitudinal Changes in Metabolic Risk Factors
Ingelsson, E., Pencina, M. J., Tofler, G. H., Benjamin, E. J., Lanier, K. J., Jacques, P. F., Fox, C. S., Meigs, J. B., Levy, D. A., Larson, M. G., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.708537 · Cited by 195
The Role of the Renin-Angiotensin-Aldosterone System in Obesity-Related Renal Diseases
Rüster, C., & Wolf, G. (2013) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2012.12.002 · Cited by 192
Nighttime Blood Pressure and Nocturnal Dipping Are Associated With Daytime Urinary Sodium Excretion in African Subjects
Bankir, L., Bochud, M., Maillard, M. P., Bovet, P., Gabriel, A., & Burnier, M. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.105510 · Cited by 192
The Link Between the Renin-Angiotensin-Aldosterone System and Renal Injury in Obesity and the Metabolic Syndrome
Thethi, T. K., Kamiyama, M., & Kobori, H. (2012) · Current Hypertension Reports · doi:10.1007/s11906-012-0245-z · Cited by 184
The Renal Pathology of Obesity
Tsuboi, N., Okabayashi, Y., Shimizu, A., & Yokoo, T. (2017) · Kidney International Reports · doi:10.1016/j.ekir.2017.01.007 · Cited by 186
The underlying mechanisms for development of hypertension in the metabolic syndrome
Yanai, H., Tomono, Y., Ito, K., Furutani, N., Yoshida, H., & Tada, N. (2008) · Nutrition Journal · doi:10.1186/1475-2891-7-10 · Cited by 171
Salt-Induced Nephropathy in Obese Spontaneously Hypertensive Rats Via Paradoxical Activation of the Mineralocorticoid Receptor
Nagase, M., Matsui, H., Shibata, S., Gotoda, T., & Fujita, T. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.091058 · Cited by 157
Aldosterone and arterial hypertension
Tomaschitz, A., Pilz, S., Ritz, E., Obermayer-Pietsch, B. M., & Pieber, T. R. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.263 · Cited by 155
Insulin Resistance and Hyperinsulinemia Are Related to Plasma Aldosterone Levels in Hypertensive Patients
Colussi, G., Catena, C., Lapenna, R., Nadalini, E., Chiuch, A., & Sechi, L. A. (2007) · Diabetes Care · doi:10.2337/dc07-0525 · Cited by 155
Aldosterone: Role in the Cardiometabolic Syndrome and Resistant Hypertension
Whaley‐Connell, A. T., Johnson, M. S., & Sowers, J. R. (2010) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2009.12.004 · Cited by 155
Salt, aldosterone, and insulin resistance: impact on the cardiovascular system
Lastra, G., Dhuper, S., Johnson, M. S., & Sowers, J. R. (2010) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2010.123 · Cited by 159
Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management
Scaroni, C., Zilio, M., Foti, M., & Boscaro, M. (2017) · Endocrine Reviews · doi:10.1210/er.2016-1105 · Cited by 140
Marked association between obesity and glomerular hyperfiltration: a cross-sectional study in an African population.
Wuerzner, G., Pruijm, M., Maillard, M., Bovet, P., Renaud, C., Burnier, M., & Bochud, M. (2010) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2010.03.017 · Cited by 129
Mineralocorticoid Receptors, Salt-Sensitive Hypertension, and Metabolic Syndrome
Fujita, T. (2010) · Hypertension · doi:10.1161/hypertensionaha.109.149062 · Cited by 130
Mineralocorticoid Receptor-Associated Hypertension and Its Organ Damage: Clinical Relevance for Resistant Hypertension
Shibata, H., & Itoh, H. (2012) · American Journal of Hypertension · doi:10.1038/ajh.2011.245 · Cited by 134
Low-dose spironolactone reduces reactive oxygen species generation and improves insulin-stimulated glucose transport in skeletal muscle in the TG(mRen2)27 rat
Lastra, G., Whaley-Connell, A., Manrique, C., Habibi, J., Gutweiler, A. A., Appesh, L., Hayden, M. R., Wei, Y., Ferrario, C., & Sowers, J. R. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00258.2007 · Cited by 119
Elevated Mineralocorticoid Receptor Activity in Aged Rat Vascular Smooth Muscle Cells Promotes a Proinflammatory Phenotype via Extracellular Signal-Regulated Kinase 1/2 Mitogen-Activated Protein Kinase and Epidermal Growth Factor Receptor-Dependent Pathways
Krug, A. W., Allenhöfer, L., Monticone, R. E., Spinetti, G., Gekle, M., Wang, M., & Lakatta, E. G. (2010) · Hypertension · doi:10.1161/hypertensionaha.109.148783 · Cited by 115
Metabolic syndrome according to different definitions in a rapidly developing country of the African region
Kelliny, C., William, J., Riesen, W., Paccaud, F. M., & Bovet, P. (2008) · Cardiovascular Diabetology · doi:10.1186/1475-2840-7-27 · Cited by 113
Aldosterone decreases glucose-stimulated insulin secretion in vivo in mice and in murine islets
Luther, J. M., Luo, P., Kreger, M. T., Brissova, M., Dai, C., Whitfield, T. T., Kim, H. S., Wasserman, D. H., Powers, A. C., & Brown, N. J. (2011) · Diabetologia · doi:10.1007/s00125-011-2158-9 · Cited by 109
Risk of new-onset diabetes mellitus in primary aldosteronism
Wu, V., Chueh, S., Chen, L., Chang, C., Hu, Y., Lin, Y., Wu, K., & Yang, W. (2017) · Journal of Hypertension · doi:10.1097/hjh.0000000000001361 · Cited by 106
Aldosterone and Metabolic Syndrome
Krug, A. W., & Ehrhart‐Bornstein, M. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.109439 · Cited by 103
Adipocytes, aldosterone and obesity-related hypertension
Cat, A. N. D., Friederich‐Persson, M., White, A. D., & Touyz, R. M. (2016) · Journal of Molecular Endocrinology · doi:10.1530/jme-16-0025 · Cited by 94
The role of obesity in the pathogenesis of hypertension
Bogaert, Y. E., & Linas, S. L. (2008) · Nature Reviews Nephrology · doi:10.1038/ncpneph1022 · Cited by 95
A possible association between primary aldosteronism and a lower β-cell function
Mosso, L. M., Carvajal, C. A., Maiz, A., Ortiz, E. H., Castillo, C. R., Artigas, R. A., & Fardella, C. E. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3282861fa4 · Cited by 94
The Role of Aldosterone in the Metabolic Syndrome
Briet, M. B., & Schiffrin, E. L. (2011) · Current Hypertension Reports · doi:10.1007/s11906-011-0182-2 · Cited by 98
Aldosterone excess impairs first phase insulin secretion in primary aldosteronism
Fischer, E., Adolf, C., Pallauf, A., Then, C., Bidlingmaier, M., Beuschlein, F., Seissler, J., & Reincke, M. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3934 · Cited by 88
Circulating Aldosterone and Natriuretic Peptides in the General Community
Buglioni, A., Cannone, V., Cataliotti, A., Sangaralingham, S. J., Heublein, D. M., Scott, C. G., Bailey, K. R., Rodeheffer, R. J., Dessı̀-Fulgheri, P., Sarzani, R., et al. (2014) · Hypertension · doi:10.1161/hypertensionaha.114.03936 · Cited by 85
Mineralocorticoid receptors in the metabolic syndrome
Zennaro, M., Caprio, M., & Fève, B. (2009) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2009.05.006 · Cited by 84
The regulation of aldosterone secretion by leptin
Faulkner, J., Bruder-Nascimento, T. B., & de Chantemèle, E. J. B. (2017) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000384 · Cited by 85
Adipokines and Cardiometabolic Profile in Primary Hyperaldosteronism
Iacobellis, G., Petramala, L., Cotesta, D., Pergolini, M., Zinnamosca, L., Cianci, R., Toma, G. D., Sciomer, S., & Letizia, C. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2204 · Cited by 80
Aldosterone in salt-sensitive hypertension and metabolic syndrome
Fujita, T. (2008) · Journal of Molecular Medicine · doi:10.1007/s00109-008-0343-1 · Cited by 79
Aldosterone and glomerular podocyte injury
Nagase, M., & Fujita, T. (2008) · Clinical and Experimental Nephrology · doi:10.1007/s10157-008-0034-9 · Cited by 79
The Role of Aldosteronism in Causing Obesity-Related Cardiovascular Risk
Calhoun, D. A., & Sharma, K. (2010) · Cardiology Clinics · doi:10.1016/j.ccl.2010.04.001 · Cited by 74
The novel non‐steroidal MR antagonist finerenone improves metabolic parameters in high‐fat diet‐fed mice and activates brown adipose tissue via AMPK‐ATGL pathway
Marzolla, V., Feraco, A., Gorini, S., Mammi, C., Marrese, C., Mularoni, V., Boitani, C., Lombès, M., Kolkhof, P., Ciriolo, M. R., et al. (2020) · The FASEB Journal · doi:10.1096/fj.202000164r · Cited by 75
Aldosterone and Cardiovascular Disease
Gaddam, K. K., Pimenta, E., Husain, S., & Calhoun, D. A. (2009) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2008.10.002 · Cited by 68
The prevalence of metabolic syndrome and its components in two main types of primary aldosteronism
Šomlóová, Z., Widimský, J., Rosa, J., Wichterle, D., Štrauch, B., Petrák, O., Zelinka, T., Vlková, J., Mašek, M., Dvořáková, J., et al. (2010) · Journal of Human Hypertension · doi:10.1038/jhh.2010.65 · Cited by 68
Aldosterone, C-Reactive Protein, and Plasma B-Type Natriuretic Peptide Are Associated With the Development of Metabolic Syndrome and Longitudinal Changes in Metabolic Syndrome Components
Musani, S. K., Vasan, R. S., Bidulescu, A., Liu, J., Xanthakis, V., Sims, M., Gawalapu, R. K., Samdarshi, T. E., Steffes, M. W., Taylor, H. A., et al. (2013) · Diabetes Care · doi:10.2337/dc12-2562 · Cited by 66
Mineralocorticoid receptor activation in obesity hypertension
Nagase, M., & Fujita, T. (2009) · Hypertension Research · doi:10.1038/hr.2009.86 · Cited by 64
Mineralocorticoid receptor overactivation: targeting systemic impact with non-steroidal mineralocorticoid receptor antagonists
Savarese, G., Lindberg, F., Filippatos, G. S., Butler, J., & Anker, S. D. (2023) · Diabetologia · doi:10.1007/s00125-023-06031-1 · Cited by 64
The role of radiologic studies in the evaluation and management of primary hyperaldosteronism
White, M. L., Gauger, P. G., Doherty, G. M., Cho, K. J., Thompson, N. W., Hammer, G. D., & Miller, B. S. (2008) · Surgery · doi:10.1016/j.surg.2008.07.025 · Cited by 62
Mineralocorticoid antagonism enhances brown adipose tissue function in humans: A randomized placebo‐controlled cross‐over study
Thuzar, M., Law, W. P., Dimeski, G., Stowasser, M., & Ho, K. K. Y. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13539 · Cited by 61
Abnormal Aldosterone Physiology and Cardiometabolic Risk Factors
Vaidya, A., UNDERWOOD, P. C., Hopkins, P. N., Jeunemaı̂tre, X., Ferri, C., Williams, G. H., & Adler, G. K. (2013) · Hypertension · doi:10.1161/hypertensionaha.111.00662 · Cited by 58
New Pandemic: Obesity and Associated Nephropathy
Sharma, I., Liao, Y., Zheng, X., & Kanwar, Y. S. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.673556 · Cited by 62
Association of plasma aldosterone with the metabolic syndrome in two German populations
Hannemann, A., Meisinger, C., Bidlingmaier, M., Döring, A., Thorand, B., Heier, M., Belcredi, P., Ladwig, K., Wallaschofski, H., Friedrich, N., et al. (2011) · European Journal of Endocrinology · doi:10.1530/eje-10-1074 · Cited by 57
Role of the Renin-Angiotensin System and Aldosterone on Cardiometabolic Syndrome
Stiefel, P., Vallejo‐Vaz, A. J., Morillo, J. S. G., & Villar, J. (2011) · International Journal of Hypertension · doi:10.4061/2011/685238 · Cited by 56
PF-03882845, a non-steroidal mineralocorticoid receptor antagonist, prevents renal injury with reduced risk of hyperkalemia in an animal model of nephropathy
Orena, S., Maurer, T. S., She, L., Eudy, R. J., Bernardo, V., Dash, D., Loria, P. M., Banker, M. E., Tugnait, M., Okerberg, C. V., et al. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00115 · Cited by 54
The NLPR3 inflammasome and obesity‐related kidney disease
Ke, B., Shen, W., Fang, X., & Wu, Q. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13333 · Cited by 54
Impact of Adrenal Steroids on Regulation of Adipose Tissue
Infante, M., Armani, A., Mammi, C., Fabbri, A., & Caprio, M. (2017) · Comprehensive physiology · doi:10.1002/cphy.c160037 · Cited by 58
Insulin resistance and salt-sensitive hypertension in metabolic syndrome
Fujita, T. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm409 · Cited by 50
Aldosterone and Cardiovascular Disease
Calhoun, D. A. (2006) · Circulation · doi:10.1161/circulationaha.106.668715 · Cited by 50
Metabolic Syndrome, Chronic Kidney Disease, and Cardiovascular Disease: A Dynamic and Life-Threatening Triad
Raimundo, M. R., & Lopes, J. A. (2011) · Cardiology Research and Practice · doi:10.4061/2011/747861 · Cited by 54
Long-term spironolactone treatment reduces coronary TRPC expression, vasoconstriction, and atherosclerosis in metabolic syndrome pigs
Li, W., Chen, X., Riley, A. M., Hiett, S. C., Temm, C. J., Beli, E., Long, X., Chakraborty, S., Alloosh, M., White, F. A., et al. (2017) · Basic Research in Cardiology · doi:10.1007/s00395-017-0643-0 · Cited by 50
Interaction of Aldosterone and Extracellular Volume in the Pathogenesis of Obesity-Associated Kidney Disease: A Narrative Review
Bomback, A. S., & Klemmer, P. J. (2009) · American Journal of Nephrology · doi:10.1159/000209744 · Cited by 48
Aldosterone: A cardiovascular risk factor?
Funder, J. W., & Reincke, M. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.08.005 · Cited by 47
ACACβ gene (rs2268388) and AGTR1 gene (rs5186) polymorphism and the risk of nephropathy in Asian Indian patients with type 2 diabetes
Shah, V. N., Cheema, B. S., Sharma, R., Khullar, M., Kohli, H. S., Ahluwalia, T. S., Mohan, V., & Bhansali, A. (2012) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-012-1460-2 · Cited by 50
The Association of Aldosterone With Obesity-Related Hypertension and the Metabolic Syndrome
Vogt, B., Bochud, M., & Burnier, M. (2007) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2007.07.009 · Cited by 50
Links between aldosterone excess and metabolic complications: A comprehensive review
Bothou, C., Beuschlein, F., & Spyroglou, A. (2019) · Diabetes & Metabolism · doi:10.1016/j.diabet.2019.02.003 · Cited by 52
Cardiac Hypertrophy and Fibrosis in the Metabolic Syndrome: A Role for Aldosterone and the Mineralocorticoid Receptor
Essick, E. E., & Sam, F. (2011) · International Journal of Hypertension · doi:10.4061/2011/346985 · Cited by 45
Relationship between Aldosterone and the Metabolic Syndrome in Patients with Obstructive Sleep Apnea Hypopnea Syndrome: Effect of Continuous Positive Airway Pressure Treatment
Barceló, A., Piérola, J., Esquinas, C., de la Peña, M., Arqué, M., Alonso‐Fernández, A., Bauçà, J. M., Robles, J., Martín, B. B., & Barbé, F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0084362 · Cited by 44
Obesity in kidney disease: A heavyweight opponent
Felizardo, R. J. F. (2014) · World Journal of Nephrology · doi:10.5527/wjn.v3.i3.50 · Cited by 44
Mineralocorticoid receptors in the pathogenesis of insulin resistance and related disorders: from basic studies to clinical disease
Jia, G., Lockette, W. E., & Sowers, J. R. (2021) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00280.2020 · Cited by 47
Activation of the aldosterone/mineralocorticoid receptor system in chronic kidney disease and metabolic syndrome
Nagase, M. (2010) · Clinical and Experimental Nephrology · doi:10.1007/s10157-010-0298-8 · Cited by 43
Aldosterone, From (Patho)Physiology to Treatment in Cardiovascular and Renal Damage
Waanders, F., de Vries, L. V., van Goor, H., Hillebrands, J., Laverman, G. D., Bakker, S. J. L., & Navis, G. J. (2011) · Current Vascular Pharmacology · doi:10.2174/157016111796642689 · Cited by 41
The Mineralocorticoid Receptor in Salt-Sensitive Hypertension and Renal Injury
Ayuzawa, N., & Fujita, T. (2021) · Journal of the American Society of Nephrology · doi:10.1681/asn.2020071041 · Cited by 42
Mineralocorticoid Receptor Blockers: Novel Selective Nonsteroidal Mineralocorticoid Receptor Antagonists
Sueta, D., Yamamoto, E., & Tsujita, K. (2020) · Current Hypertension Reports · doi:10.1007/s11906-020-1023-y · Cited by 39
New roles of aldosterone and mineralocorticoid receptors in cardiovascular disease: translational and sex-specific effects
Davel, A. P., Jaffe, I. Z., Tostes, R. C., Jaisser, F., & de Chantemèle, E. J. B. (2018) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00073.2018 · Cited by 39
The mineralocorticoid receptor—an emerging player in metabolic syndrome?
Thuzar, M., & Stowasser, M. (2021) · Journal of Human Hypertension · doi:10.1038/s41371-020-00467-3 · Cited by 38
Investigation Into the Cardiac Effects of Spironolactone in the Experimental Model of Type 1 Diabetes
Goyal, B. R., Solanki, N. D., Goyal, R. K., & Mehta, A. A. (2009) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3181be75cc · Cited by 37
Risk factor assessment for new onset diabetes: literature review
Bakris, G. L., Stockert, J., Molitch, M. E., Zhou, Q., Champion, A., Bacher, P. H., Sowers, J. R., & on behalf of the STAR Investigators (2008) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00925.x · Cited by 36
Mineralocorticoid receptors in the pathophysiology of chronic kidney diseases and the metabolic syndrome
Shibata, S., & Fujita, T. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.07.018 · Cited by 34
Role of Mitogen-Activated Protein Kinase Pathways in Multifactorial Adverse Cardiac Remodeling Associated with Metabolic Syndrome
Asrih, M., Mach, F., Nencioni, A., Dallegri, F., Quercioli, A., & Montecucco, F. (2013) · Mediators of Inflammation · doi:10.1155/2013/367245 · Cited by 35
Mineralocorticoid receptor–Rac1 activation and oxidative stress play major roles in salt-induced hypertension and kidney injury in prepubertal rats
Kawarazaki, H., Ando, K., Shibata, S., Muraoka, K., Fujita, M., Kawarasaki, C., & Fujita, T. (2012) · Journal of Hypertension · doi:10.1097/hjh.0b013e3283576904 · Cited by 35
Aldosterone and aldosterone: renin ratio associations with insulin resistance and blood pressure in African Americans
Huan, Y., DeLoach, S. S., Keith, S. W., Goodfriend, T. L., & Falkner, B. E. (2011) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2011.09.005 · Cited by 33
Mineralocorticoid Receptor and Aldosterone-Related Biomarkers of End-Organ Damage in Cardiometabolic Disease
Gorini, S., Marzolla, V., Mammi, C., Armani, A., & Caprio, M. (2018) · Biomolecules · doi:10.3390/biom8030096 · Cited by 36
Bariatric surgery and hypertension
Bueter, M., Ahmed, A. R., Ashrafian, H., & le Roux, C. W. (2009) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2009.03.218 · Cited by 34
Plasma Aldosterone and Its Relationships With Left Ventricular Mass in Essential Hypertensive Patients With the Metabolic Syndrome
Mulè, G., Nardi, E., Cusimano, P., Cottone, S., Seddio, G., Geraci, C., Palermo, A., Andronico, G., & Cerasola, G. (2008) · American Journal of Hypertension · doi:10.1038/ajh.2008.225 · Cited by 33
Renal tubule insulin receptor modestly promotes elevated blood pressure and markedly stimulates glucose reabsorption
Nizar, J. M., Shepard, B. D., Vo, V., & Bhalla, V. (2018) · JCI Insight · doi:10.1172/jci.insight.95107 · Cited by 33
The Renal Pathology of Obesity: Structure-Function Correlations
Tsuboi, N., & Okabayashi, Y. (2021) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2021.06.002 · Cited by 34
Physiological Aldosterone Concentrations Are Associated with Alterations of Lipid Metabolism: Observations from the General Population
Hannich, M. J., Wallaschofski, H., Nauck, M. A., Reincke, M., Adolf, C., Völzke, H., Rettig, R., & Hannemann, A. (2018) · International Journal of Endocrinology · doi:10.1155/2018/4128174 · Cited by 31
Association of Reversal of Renin Suppression With Long-Term Renal Outcome in Medically Treated Primary Aldosteronism
Katsuragawa, S., Goto, A., Shinoda, S., Inoue, K., Nakai, K., Saito, J., Nishikawa, T., & Tsurutani, Y. (2023) · Hypertension · doi:10.1161/hypertensionaha.123.21096 · Cited by 31
Hypertension, Insulin Resistance, and Aldosterone: Sex‐Specific Relationships
Kidambi, S., Kotchen, J. M., Krishnaswami, S., Grim, C. E., & Kotchen, T. A. (2009) · Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2009.00084.x · Cited by 30
−344C/T Variant in the Promoter of the Aldosterone Synthase Gene (CYP11B2) Is Associated With Metabolic Syndrome in Men
Russo, P., Lauria, F., Loguercio, M., Barba, G., Arnout, J., Cappuccio, F. P., Delorgeril, M., Donati, M. B., Iacoviello, L., & Krogh, V. (2007) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2006.07.012 · Cited by 29
Subclinical Primary Aldosteronism and Major Adverse Cardiovascular Events: A Longitudinal Population-Based Cohort Study
Goupil, R., Desbiens, L., Merabtine, A., Agharazii, M., Madore, F., Vaidya, A., Leung, A. A. C., Kline, G. A., Shaw, J. L. V., Ramsay, T., et al. (2025) · Circulation · doi:10.1161/circulationaha.124.073507 · Cited by 30
Aldosterone-to-Renin Ratio and the Relationship Between Urinary Salt Excretion and Blood Pressure in a Community of African Ancestry
Scott, L., Woodiwiss, A. J., Maseko, M. J., Veliotes, D. G. A., Majane, O. H. I., Paiker, J. E., Sareli, P., & Norton, G. R. (2011) · American Journal of Hypertension · doi:10.1038/ajh.2011.49 · Cited by 28
Associations of the -344 T>C and the 3097 G>A Polymorphisms of CYP11B2 Gene With Hypertension, Type 2 Diabetes, and Metabolic Syndrome in a French Population
Bellili-Muñoz, N., Foucan, L., Fumeron, F., Mohammedi, K., Travert, F., Roussel, R., Balkau, B., Tichet, J., Marre, M., & ; the D.E.S.I.R. Study Group (2010) · American Journal of Hypertension · doi:10.1038/ajh.2010.44 · Cited by 27
The necessity and effectiveness of mineralocorticoid receptor antagonist in the treatment of diabetic nephropathy
Sato, A. (2015) · Hypertension Research · doi:10.1038/hr.2015.19 · Cited by 26
The metabolic syndrome in primary aldosteronism
Fallo, F., Federspil, G., Veglio, F., & Mulatero, P. (2008) · Current Diabetes Reports · doi:10.1007/s11892-008-0009-y · Cited by 28
A critical review of the evidence supporting aldosterone in the etiology and its blockade in the treatment of obesity-associated hypertension
Byrd, J. B., & Brook, R. D. (2014) · Journal of Human Hypertension · doi:10.1038/jhh.2013.42 · Cited by 25
Sex Differences in Leptin Control of Cardiovascular Function in Health and Metabolic Diseases
de Chantemèle, E. J. B. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-70178-3_6 · Cited by 27
Primary aldosteronism is associated with decreased low‐density and high‐density lipoprotein particle concentrations and increased GlycA, a pro‐inflammatory glycoprotein biomarker
Berends, A. M. A., Buitenwerf, E., Gruppen, E. G., Sluiter, W. J., Bakker, S. J. L., Connelly, M. A., Kerstens, M. N., & Dullaart, R. P. F. (2018) · Clinical Endocrinology · doi:10.1111/cen.13891 · Cited by 24
The Association of Life’s Simple 7 with Aldosterone among African Americans in the Jackson Heart Study
Kesireddy, V., Tan, Y., Kline, D., Brock, G. N., Odei, J. B., Kluwe, B., Effoe, V. S., Echouffo-Tcheugui, J. B., Kalyani, R. R., Sims, M., et al. (2019) · Nutrients · doi:10.3390/nu11050955 · Cited by 23

Authors: Bochud, M., Nussberger, J., Bovet, P., Maillard, M. R., Elston, R. C., Paccaud, F., Shamlaye, C., & Burnier, M.
Affiliations: Centre Hospitalier Universitaire Vaudois (CH)
From the Department of Epidemiology and Biostatistics (M. Bochud, R.C.E.), Case Western Reserve University, Cleveland, Ohio; Institut Universitaire de Médecine Sociale et Préventive (M. Bochud, P.B., F.P.), Lausanne, Switzerland; Département de Médecine et Service de Néphrologie (J.N., M.R.M., M. Burnier), Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; and the Ministry of Health (P.B., C.S.), Victoria, Seychelles.
ORCID: Bochud, Murielle
Bovet, Pascal
Elston, Robert C.
Burnier, Michel
Venue: Hypertension
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2006-08
Volume: 48
Issue: 2
Pages: 239-245
ISSN: 0194-911X (ISSN-L)
1524-4563
DOI: 10.1161/01.hyp.0000231338.41548.fc
OpenAlex: W2124037655
Cited by: 226
References: 55
Citations by year: 2026: 4 · 2025: 9 · 2024: 4 · 2023: 6 · 2022: 12 · 2021: 12 · 2020: 5 · 2019: 5 · 2018: 14 · 2017: 13 · 2016: 3 · 2015: 10 · 2014: 13 · 2013: 14 · 2012: 14
FWCI: 12.91
Type: journal article
Language: en
Open access: closed
Locations: Hypertension (publishedVersion)
PubMed (publishedVersion)
IRIS (submittedVersion)
SERVAL (Université de Lausanne) (submittedVersion)
Funders: Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
National Institute of General Medical Sciences (GM-28356)
National Center for Research Resources (RR-03655, P41RR003655)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords: plasma aldosterone, plasma renin activity, metabolic syndrome, blood pressure, waist circumference, HDL cholesterol, potassium excretion, triglycerides, fasting blood glucose, cardiovascular risk, African ancestry
MeSH terms: Africa, Eastern, Aldosterone, Blood Pressure, Female, Humans, Male, Middle Aged, Regression Analysis, Renin, Risk Factors, Seychelles, Models, Statistical, Metabolic Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Plasma Aldosterone Is Independently Associated With the Metabolic Syndrome

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks